|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/573 | |
| A61K 31/55 | |||
| A61K 9/12 | |||
| A61P 11/02 |
| (11) | Patento numeris | 2647380 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11845222.6 |
| Europos patento paraiškos padavimo data | 2011-11-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2011/008826 |
| Data | 2011-11-18 |
| (87) | Numeris | WO 2012/074231 |
| Data | 2012-06-07 |
| (30) | Numeris | Data | Šalis |
| 20100119632 | 2010-11-29 | KR |
| (72) |
LEE, Sang-Yong, KR
LEE, Geun-Hyeog, KR
CHOI, Byong-Sun, KR
RYU, Jong-Hyeon, KR
PARK, Jin-Ha, KR
O, Mi-Jin, KR
|
| (73) |
Hanlim Pharmaceutical Co., Ltd.,
1007 Yubang-dong Cheoin-gu Yongin-si, Gyeonggi-do 449-935,
KR
|
| (54) | PHARMACEUTICAL COMPOSITION INCLUDING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION |
| PHARMACEUTICAL COMPOSITION INCLUDING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION |